We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Constellation Healthcare Technologies | LSE:CHT | London | Ordinary Share | CMN SHS USD0.0001 (DI/REG S) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 216.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMCHT
RNS Number : 7928E
Constellation Healthcare Tech, Inc
21 July 2016
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL
21 July 2016
Constellation Healthcare Technologies, Inc.
("Constellation", "CHT" or "the Group")
Trading Update
Constellation Healthcare Technologies, the US-based healthcare services and technology Company, is pleased to announce that, internal unaudited financial Revenue, Cash from Operations and Operating Profit in the first half of 2016 are in line with board expectations for FY 2016. Revenue for the Full Year is expected to be in excess of $126.5 million.
The company is now debt free, and continues to win new business organically. This is expected to continue during the rest of the year. The Company is also evaluating a number of acquisition opportunities and will update the market in due course.
Paul Parmar, Chief Executive Officer of Constellation commented, "CHT continues to grow its business organically demonstrating both demand for its services and the strength of the technology suite. The Company is operating in a strong US medical billing market, and the stage is set for a robust first half financial performance in 2016."
Enquiries:
Constellation Healthcare Technologies c/o Redleaf Communications Paul Parmar, Chief Executive +44 (0)20 7382 4730 Officer finnCap - Nominated Adviser and Joint Broker Julian Blunt / Scott Mathieson +44 (0)20 7220 0500 Stifel - Joint Broker Jonathan Senior / Ben Maddison +44 (0)20 7710 7600 Redleaf Communications - PR +44 (0)20 7382 4730 adviser constellation@redleafpr.com Charlie Geller / Sam Modlin
This information is provided by RNS
The company news service from the London Stock Exchange
END
TSTZMGZNVGDGVZM
(END) Dow Jones Newswires
July 21, 2016 02:00 ET (06:00 GMT)
1 Year Constellation Healthcare Chart |
1 Month Constellation Healthcare Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
